A Plan for Peace of Mind
With just weeks until the QMSR effective date, a structured timeline will keep your team focused and avoid last-minute scrambles.
Q1 2026 – Finalize the Foundation
- Complete gap assessments and close high-risk findings.
- Approve the Quality Manual and Medical Device File structure.
- Confirm risk, supplier, and CAPA procedures are revised.
- Train teams and verify competence on new requirements.
Goal: Demonstrate readiness by the February 2 deadline.
Q2 2026 – Validate and Verify
- Conduct a mock FDA inspection using QMSR criteria.
- Evaluate CAPA effectiveness and supplier performance.
- Begin collecting data for your first post-transition management review.
Goal: Turn the new system into daily habit.
Q3 2026 – Optimize and Trend
- Analyze CAPA and audit trends to spot systemic issues.
- Update supplier scorecards and risk tiers.
- Refresh training programs based on real audit feedback.
Goal: Shift from transition mode to continuous improvement mode.
Q4 2026 – Sustain and Improve
- Conduct a full annual internal audit under QMSR.
- Use management review to set 2027 quality objectives.
- Celebrate successes — compliance sustained is compliance earned.
Your Partner for the Long Game
Compliance Insight has helped medical device companies navigate regulatory evolution since 2000. We believe structure brings confidence — and QMSR is an opportunity to build a system that lasts.
Contact us today to discover how Compliance Insight can support your company with everything related to QMSR.
